US Patent Issued to The Brigham and Women's Hospital on Jan. 20 for "Brevican-binding peptides for brain tumor imaging" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,835, issued on Jan. 20, was assigned to The Brigham and Women's Hospital Inc. (Boston).

"Brevican-binding peptides for brain tumor imaging" was invented by Choi-Fong Cho (Boston), Sean Edward Lawler (Scituate, Mass.) and Mariano Sebastian Viapiano (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising peptides that bind specifically to Btriangleg (deglycosylated brevican), and methods of use thereof to deliver therapeutic and diagnostic agents to brevican-expressing cells, e.g., cancerous cells, e.g., brain cancer cells, e.g., glioblastoma cells."

The patent was filed on Oct. 1, 2019, under Applica...